Running out of drug test devices mid shift is a small problem that turns into a big one fast. A collection gets delayed, a court deadline slips, a new hire sits idle on day one. Carrying too much stock has its own cost: devices expire, storage space gets tight, and money sits in a box instead of in the business. The fix is not guesswork. It is a simple reorder planning method built on the numbers you already have: how many tests you run by type, how predictable that volume is, how long it takes a reorder to arrive, and how long a device stays good on the shelf.
This guide walks through that method with worked examples for a treatment center, a staffing branch and a probation office, plus the questions to ask before you pick a product class in the first place.
Start with product class, because it drives everything else
Before you can plan quantities, you need to know what you are actually ordering. The major rapid test formats used in clinics, treatment programs, staffing and court settings are urine test cups, urine dip cards, and oral fluid (saliva) devices. Each behaves differently in terms of collection setting, read time, and the labeling that governs how the result can be used.
| Product class | Collection setting | Typical read time | Labeling to check | Common use |
|---|---|---|---|---|
| Urine test cups | Restroom, integrated cup with built in strips | About 5 minutes | CLIA waived for point of care use, or forensic use only | Treatment programs, employer pre employment and random panels |
| Urine dip cards | Any collected urine sample, strips dipped by staff | About 5 minutes | CLIA waived or forensic use only, varies by model | Clinics and programs that already have a specimen collection workflow |
| Oral fluid devices | Observed collection, no restroom needed | About 5 to 10 minutes | CLIA waived status varies by device, check the specific product | Staffing, DOT and observed collection settings |
| Confirmation (lab) | Split specimen sent to a laboratory | Days, not minutes | Lab operates under its own CLIA certificate | Non negative screens, disputed results, probation and MRO review |
Within any of these classes, the panel (how many drugs the device screens for), the cutoff concentrations, and whether the device includes an adulterant check (checking for dilution, pH, or oxidants in the specimen) all vary by product. A device cleared for one setting is not automatically appropriate for another. Whether a specific device is CLIA waived for point of care use, rather than labeled for forensic or laboratory use only, is listed in the FDA's own CLIA database of waived analytes, and that is the record to check rather than assuming based on the packaging alone. The underlying Clinical Laboratory Improvement Amendments program itself is jointly administered with the Centers for Medicare and Medicaid Services (CMS).
Federal workplace programs add another layer. Employers and programs covered by DOT 49 CFR Part 40 must follow specific collection, device, and laboratory confirmation requirements, and the underlying federal scientific and technical requirements for drug testing programs are set out in guidelines published through the Federal Register's mandatory guidelines for federal workplace drug testing programs. If your program is not a federally regulated one, those specific cutoffs and procedures do not automatically apply, but many employers choose to mirror them anyway for consistency.
Build your number from monthly volume, not a guess
The reorder planning method has five inputs. Once you have them for each product type you actually use, the math is the same every time.
- Average monthly volume by type. Pull this from your own order history or intake log: how many urine cups, dip cards, or oral fluid devices did you actually use last month, broken out by panel if you run more than one.
- Safety stock for spikes. New hire waves, random testing pulls, and court ordered testing days do not spread evenly across the month. A common starting point is to hold extra stock equal to your single busiest week, on top of the average.
- Lead time. How many days or weeks from placing a reorder to the stock arriving and being ready to use, including any internal approval steps.
- Shelf life. Rapid test devices are typically dated with a shelf life in the 12 to 24 month range from manufacture, but this varies by product and manufacturer. Check the box and the package insert for the actual expiration date rather than assuming a number.
- Storage conditions. Most rapid devices specify a room temperature range on the label. Stock stored outside that range, in a hot vehicle or a damp storage room, can degrade before the printed date.
The reorder point formula
A straightforward version of the classic reorder point formula works well for test devices:
Reorder point = (average daily use x lead time in days) + safety stock
When your on hand stock drops to that number, it is time to place the next order, not after you run out.
Three worked examples
| Setting | Average monthly volume | Lead time | Safety stock | Reorder point |
|---|---|---|---|---|
| Treatment center (daily intake testing) | 300 urine cups | 7 days | 1 busy week, about 90 units | About 160 units (10/day x 7 days = 70, plus 90 safety stock) |
| Staffing branch (pre employment plus random) | 150 oral fluid devices | 5 days | 50 units for hiring surges | About 75 units (5/day x 5 days = 25, plus 50 safety stock) |
| Probation office (scheduled check ins) | 200 dip cards | 10 days | 40 units for added check in days | About 107 units (6.7/day x 10 days = 67, plus 40 safety stock) |
These numbers are illustrative starting points, not a formula any program must follow. Recalculate using your own volume and your own supplier's actual lead time, and revisit the numbers every few months as your caseload or workforce changes.
Rotate stock and keep expired devices out of circulation
Buying in the right quantity solves half the problem. The other half is making sure older stock gets used before newer stock, so nothing sits past its expiration date. A few practical habits:
- Use a first in, first out shelf arrangement: new cases go to the back, staff pull from the front.
- Write or confirm the expiration date on each case when it arrives, and flag anything expiring within the next few months for priority use.
- Do not use a device past its printed expiration date. A control line that looks normal does not override an expired date; manufacturers only validate performance through the date on the label.
- Store devices within the temperature range printed on the package insert, away from direct sunlight, and away from freezing or excessive heat in a vehicle or uninsulated storage area.
- If a non negative result or a disputed result needs further review, confirmation testing and the medical review officer process are the next step, not a second rapid device.
Use order history and reorder tools instead of a spreadsheet alone
Business accounts with an actual supplier typically give you tools that make the formula above easier to maintain without rebuilding it from scratch every quarter. A wholesale business account, such as the one at wholesale.americanscreeningcorp.com, generally offers net terms, a purchase order checkout flow, and order history that shows exactly what you bought and when, which is the raw data your average monthly volume number comes from. One click reorder on a previous order, or a standing subscription for a steady volume product, removes the manual step of re-entering quantities every time and helps keep your reorder point from slipping past the deadline.
For programs that order a mix of cups, dip cards, and oral fluid devices across multiple panels, keeping that order history by product type is what makes the monthly volume input in the formula accurate instead of estimated.
A note on kratom and other newer analytes
If your program is adding or considering a kratom (mitragynine) component, know that a standard multi drug panel does not screen for it. Detecting mitragynine requires a dedicated KRA strip or panel position, and rapid immunoassay panels in general do not detect related compounds such as 7-OH or other emerging analytes. If a result needs to confirm a specific substance beyond what your panel screens for, ask the confirmation laboratory directly which analytes its method covers before assuming a negative screen rules anything out.
Frequently asked questions
How far in advance should we place a reorder?
Use your supplier's actual lead time, not an estimate. Add that number of days of average use to your safety stock to get your reorder point, and place the order as soon as on hand stock reaches that level rather than waiting until stock runs low.
How long do drug test devices typically last on the shelf?
Shelf life varies by manufacturer and product, but rapid test devices are typically dated in the 12 to 24 month range from the manufacture date. Always check the expiration date printed on the individual box rather than assuming a standard timeframe.
Is it better to overstock to avoid running out?
Not usually. Overstocking ties up money and shelf space and increases the chance that devices expire before they are used. A calculated safety stock, sized to your actual busiest periods, covers spikes without the waste of a much larger buffer.
Does CLIA waived status matter when I am choosing how much to stock?
Yes, because it affects where a device can legally be used. CLIA waived devices are cleared for point of care use in a broader range of settings, while forensic use only devices are restricted to settings with appropriate laboratory oversight. Check a device's current status in the FDA's CLIA database before committing to a large order of a given product.
What should we do with stock that is close to expiring?
Move it to the front of your rotation and prioritize it for near term use. If it will expire before it can reasonably be used, do not use it past the printed date; treat it as a loss and adjust future order quantities to reduce that kind of overstock going forward.
Can a rapid test panel detect kratom or newer synthetic substances?
Only if the panel specifically includes that analyte. A standard opiate or multi drug panel does not detect mitragynine (kratom); that requires a dedicated KRA strip. For any substance not listed on the panel's analyte list, confirmation testing at a laboratory is the reliable route, and the lab can tell you exactly which analytes its confirmation method covers.
Related reading
- Do Drug Test Cups Expire? Shelf Life and Storage Guide for Bulk Buyers
- CLIA-Waived Drug Test Cups: What Buyers Should Know
Browse drug test cups, or explore oral fluid devices and dip cards to compare panels and formats before placing a reorder.
This article is general information for planning purposes, not legal, medical, or regulatory advice. Program requirements vary by jurisdiction and employer policy; consult qualified counsel or your program administrator for your specific situation.
